Section Arrow
PTCT.NASDAQ
- PTC Therapeutics
Quotes are at least 15-min delayed:2025/07/20 18:37 EDT
Regular Hours
Last
 47.63
-0.9 (-1.85%)
Day High 
49.09 
Prev. Close
48.53 
1-M High
51.285 
Volume 
628.56K 
Bid
40.06
Ask
49.5
Day Low
47.23 
Open
48.88 
1-M Low
47.28 
Market Cap 
3.85B 
Currency USD 
P/E 7.45 
%Yield -- 
10-SMA 48.54 
20-SMA 49.01 
50-SMA 48.25 
52-W High 58.38 
52-W Low 29.015 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
6.51/-1.51
Enterprise Value
6.05B
Balance Sheet
Book Value Per Share
-2.34
Cash Flow
Cash Flow Yield
0.18
Income Statement
Total Revenue
806.78M
Operating Revenue Per Share
10.07
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
NCNANuCana plc0.0477+0.0009+1.92%-- 
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Quotes are at least 15-min delayed:2025/07/20 18:37 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.